Lunit, Radiobotics team up to enter EMEA markets

The company partnered with the Denmark-based firm for distributing its chest X-ray image analysis solution Insight CXR

Lunit, Radiobotics team up to enter EMEA markets
Yena Kim 1
2024-05-02 17:24:36 yena@hankyung.com
Bio & Pharma

South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS to enter the Europe, Middle East, and Africa (EMEA) markets. 

Under the agreement, the company will distribute Radiobotics' fracture and trauma detection solution RBfracture alongside its chest X-ray image analysis solution Lunit Insight CXR in the specified region.

Radiobotics will co-distribute Lunit Insight CXR when selling its products. 

Lunit anticipates that patients in the EMEA region will benefit from the convenience of receiving comprehensive screenings for conditions ranging from lung diseases to fractures and trauma through X-ray imaging alone.

Write to Yena Kim at yena@hankyung.com
#Lunit #Radiobotics #AI diagnostics #RBfracture #Lunit Insight CXR

Lunit gets court approval for Volpara acquisition in New Zealand

Lunit gets court approval for Volpara acquisition in New Zealand

South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to acquire New Zealand-based AI breast cancer diagnostics solutions company Volpara Health Technologies.According to Lunit, the acquisition approval p

Lunit to supply AI image analysis solutions to Samsung Electronics

Lunit to supply AI image analysis solutions to Samsung Electronics

Lunit Insight CXR South Korean medical AI company Lunit has secured a significant partnership with tech giant Samsung Electronics Co., signing a three-year, $1.86 million contract to supply two of its cutting-edge AI solutions. This deal represents a substantial 17.7% of Lunit's 2022 revenue, s

Lunit acquires NZ-based AI diagnostics firm Volpara

Lunit acquires NZ-based AI diagnostics firm Volpara

South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Volpara Health Technologies for $193.07 million.Under the deal, Volpara is valued at AUD 1.15 per share. This is a 47.4% increase from its previous

Lunit selected as contractor for building medical AI platform in Singapore

Lunit selected as contractor for building medical AI platform in Singapore

Lunit's Insight CXR South Korean medical AI company Lunit announced on Friday that it has been selected as the final contractor in the bidding for the establishment of the medical AI platform "AimSG" by SYNAPSE, Singapore's state-owned healthtech agency, aimed at innovating public healthcare se

Lunit gets FDA approval for AI cancer diagnosis solution

Lunit gets FDA approval for AI cancer diagnosis solution

South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has secured 510(k) pre-market clearance from the US Food and Drug Administration (FDA).This marks Lunit's third FDA approval, joining its AI emergenc
(* comment hide *}